Related Experiment Video
Updated: Jan 3, 2026

Protocol and Guidelines for Point-of-Care Lung Ultrasound in Diagnosing Neonatal Pulmonary Diseases Based on International Expert Consensus
Published on: March 6, 2019
Pulmonary Alveolar Microlithiasis in Children Less than 5 Years of Age
Elodie Sigur1, Lea Roditis1, Geraldine Labouret1
1Children Hospital, Pediatric Pulmonology and Allergology Unit CHU Toulouse, Toulouse, France.
Objective:
To collect all published cases up to January 2019 of pulmonary alveolar microlithiasis (PAM) in patients age 5 years and under and to compare their characteristics with those of the 1022 cases in the most recent all-age cohort published in 2015.
Study Design:
We identified 28 cases of PAM worldwide in children age 5 years and under, accounting for only 2%-3% of all cases.
Results:
Children seem more frequently symptomatic, notably with more cough and severe acute respiratory failure, but had no reported extrapulmonary manifestation. Children with PAM evidenced less typical radiologic findings, with frequent ground glass opacities not reported in adult cases and milder calcifications as less frequent, smaller, and mainly restricted to the lower lobes.
Conclusions:
PAM remains an uncommon diagnosis in young children, as symptoms and radiologic findings are less specific. Physicians should be aware to look for calcifications in chest computed tomography at mediastinal window and avoid elution of the bronchoalveolar lavage to find microliths. Collecting longitudinal data through an international registry would help in characterizing PAM to predict disease progression and plan lung transplantation.
Insights
Pulmonary alveolar microlithiasis (PAM) is rare in children under 5, presenting with distinct symptoms and imaging. Early diagnosis requires awareness of subtle calcifications on CT scans and bronchoalveolar lavage analysis.
Area of Science:
- Pulmonary Medicine
- Pediatric Respiratory Diseases
- Radiology
Background:
- Pulmonary alveolar microlithiasis (PAM) is a rare lung disease characterized by diffuse calcifications.
- Understanding PAM in pediatric populations is crucial due to potential differences in presentation and progression.
Related Concept Videos
Breathing
Pulmonary Cycle: Exhalation
Pharmacokinetics in Pediatric Patients: Drug Excretion

